Literature DB >> 10529682

International immune tolerance registry, 1997 update.

G Mariani1, B Kroner.   

Abstract

Mesh：

Substances：

Year:  1999        PMID： 10529682     DOI： 10.1159/000056710

Source DB:  PubMed          Journal:  Vox Sang        ISSN： 0042-9007            Impact factor:   2.144


× No keyword cloud information.
  4 in total

Review 1.  Immune tolerance induction for patients with severe hemophilia A: a critical literature review.

Authors:  Massimo Franchini; Giuseppe Lippi
Journal:  J Thromb Thrombolysis       Date:  2011-11       Impact factor: 2.300

2.  Rituximab for treatment of inhibitors in haemophilia A. A Phase II study.

Authors:  C Leissinger; C D Josephson; S Granger; B A Konkle; R Kruse-Jarres; M V Ragni; J M Journeycake; L Valentino; N S Key; J C Gill; K R McCrae; E J Neufeld; C Manno; L Raffini; K Saxena; M Torres; V Marder; C M Bennett; S F Assmann
Journal:  Thromb Haemost       Date:  2014-06-12       Impact factor: 5.249

Review 3.  Immune tolerance induction for treating inhibitors in people with congenital haemophilia A or B.

Authors:  Abha H Athale; Maura Marcucci; Alfonso Iorio
Journal:  Cochrane Database Syst Rev       Date:  2014-04-24

4.  Final Results of the Prospective ADVATE® Immune Tolerance Induction Registry (PAIR) Study with Plasma- and Albumin-Free Recombinant Factor VIII.

Authors:  Amy D Shapiro; Alejandro Fernandez; Jerome Teitel; Jaco Botha; Kate Khair
Journal:  J Blood Med       Date:  2021-11-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.